Vabysmo(Faricimab-svoa) Instructions:Uses,Dosage, Side Effects

Neovascular (Wet) Age-Related Macular Degeneration (nAMD).

Diabetic Macular Edema (DME).

Macular Edema Following Retinal Vein Occlusion (RVO).

nAMD: 6 mg via intravitreal injection every 4 weeks for the first 4 doses, followed by individualized dosing intervals (e.g., every 8–16 weeks) based on optical coherence tomography and visual acuity assessments.

DME: Two regimens are recommended:

6 mg every 4 weeks for at least 4 doses, with subsequent interval adjustments (extended up to 4 weeks or reduced up to 8 weeks) based on central subfield thickness and visual acuity.

6 mg every 4 weeks for the first 6 doses, then every 8 weeks.

RVO: 6 mg administered every 4 weeks for 6 months.

All injections must be performed using aseptic technique.